Resolutions of the 2006 AGM
Solothurn/Switzerland, April 21, 2006The 7th Annual General Meeting of Shareholders was held on April 20, 2006 at 4 pm at the Concert Hall in Solothurn.
71'638'524 of the 114’956'315 issued and outstanding shares were represented at the AGM. The 370 shareholders attending the meeting represented 62.3% of the total capital.
The following resolutions were taken with few dissenting votes and abstentions.
Agenda item 3
Approval of the report on the financial year, the annual accounts and the consolidated accounts for 2005.
Agenda item 4
The general assembly took notice of a dividend of CHF 0.70 per share of common stock. The dividend will be paid out on April 24, 2006.
Agenda item 5
The shareholders re-elected Dr. David Helfet, André Müller and Hansjörg Wyss, MD (Hon) to the Board of Directors as Class I Directors for a term of three years. Furthermore, the shareholders elected Jobst Wagner to the Board of Directors as Class II Director for the remaining term of one year and Felix Pardo to the Board of Directors as Class I Director for a term of three years.
Agenda item 6
The shareholders ratified the selection of Ernst & Young LLP, Philadelphia, PA, as auditors of Synthes, Inc. and as Group Auditors for 2006.
Synthes: A leading medical device company
Synthes is a leading global medical device company. We develop, produce and market instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.
For further information please contact
Peter Fehlmann, Investor Relations, Synthes, Inc.
Phone: +41 32 720 48 10 , Fax: +41 32 720 48 11
e-mail: ir.info@synthes.com